Analysis of molecular and clinical progression in PCa has revealed two distinct evolutionary trajectories including SPOP mutation → CHD1 loss and ERG fusion → PTEN loss (Liu et al., 2021). The gene discussed is SPOP; the disease is posterior cortical atrophy.